Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003
Chronic obstructive pulmonary disease (COPD) is a common cause of disability and death in Canada. Moreover, morbidity and mortality from COPD continue to rise and the economic burden is enormous. The main goal of the Canadian Thoracic Society (CTS) Evidence-Based Guidelines is to optimize early diag...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2003-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2003/567598 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832550451916046336 |
|---|---|
| author | Denis E O’donnell Shawn Aaron Jean Bourbeau Paul Hernandez Darcy D Marciniuk Meyer Balter Gordon Ford Andre Gervais Roger Goldstein Rick Hodder Francois Maltais Jeremy Road |
| author_facet | Denis E O’donnell Shawn Aaron Jean Bourbeau Paul Hernandez Darcy D Marciniuk Meyer Balter Gordon Ford Andre Gervais Roger Goldstein Rick Hodder Francois Maltais Jeremy Road |
| author_sort | Denis E O’donnell |
| collection | DOAJ |
| description | Chronic obstructive pulmonary disease (COPD) is a common cause of disability and death in Canada. Moreover, morbidity and mortality from COPD continue to rise and the economic burden is enormous. The main goal of the Canadian Thoracic Society (CTS) Evidence-Based Guidelines is to optimize early diagnosis, prevention and management of COPD in Canada. Targeted spirometry is strongly recommended to expedite early diagnosis in smokers and exsmokers who develop respiratory symptoms, and who are at risk for COPD. Smoking cessation remains the single most effective intervention to reduce the risk of COPD and to slow its progression. Education, especially self-management plans, are key interventions in COPD. Therapy should be escalated in accordance with the increasing severity of symptoms and disability. Long acting anticholinergics and beta2-agonist inhalers should be prescribed for patients who remain symptomatic despite short-acting bronchodilator therapy. Inhaled
steroids should not be used as first line therapy in COPD, but have a role in preventing exacerbations in patients with more advanced disease who suffer recurrent exacerbations. Management strategies
consisting of combined modern pharmacotherapy and nonpharmacotherapeutic interventions (eg, pulmonary rehabilitation/exercise training) can effectively improve symptoms, activity levels, and quality
of life, even in patients with severe COPD. Acute exacerbations of COPD cause significant morbidity and mortality and should be treated promptly with bronchodilators and a short course of oral steroids; antibiotics should be prescribed for purulent exacerbations. Patients with advanced COPD and respiratory failure require a comprehensive management plan that incorporates structured end-of-life care. |
| format | Article |
| id | doaj-art-d658774c52494b72ac64867abb9ceeb2 |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2003-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-d658774c52494b72ac64867abb9ceeb22025-02-03T06:06:50ZengWileyCanadian Respiratory Journal1198-22412003-01-0110Suppl A11A33A10.1155/2003/567598Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003Denis E O’donnell0Shawn Aaron1Jean Bourbeau2Paul Hernandez3Darcy D Marciniuk4Meyer Balter5Gordon Ford6Andre Gervais7Roger Goldstein8Rick Hodder9Francois Maltais10Jeremy Road11Queen’s University, Kingston, Ontario, CanadaUniversity of Ottawa, Ottawa, Ontario, CanadaMcGill University, Montreal, Quebec, CanadaDalhousie University, Halifax, Nova Scotia, CanadaUniversity of Saskatchewan, Saskatoon, Saskatchewan, CanadaUniversity of Toronto, Toronto, Ontario, CanadaUniversity of Alberta, Calgary, Alberta, CanadaUniversity of Montreal, Montreal, Quebec, CanadaUniversity of Toronto, Toronto, Ontario, CanadaUniversity of Ottawa, Ottawa, Ontario, CanadaUniversity of Laval, Sainte-Foy, Quebec, CanadaUniversity of British Columbia, Vancouver, British Columbia, CanadaChronic obstructive pulmonary disease (COPD) is a common cause of disability and death in Canada. Moreover, morbidity and mortality from COPD continue to rise and the economic burden is enormous. The main goal of the Canadian Thoracic Society (CTS) Evidence-Based Guidelines is to optimize early diagnosis, prevention and management of COPD in Canada. Targeted spirometry is strongly recommended to expedite early diagnosis in smokers and exsmokers who develop respiratory symptoms, and who are at risk for COPD. Smoking cessation remains the single most effective intervention to reduce the risk of COPD and to slow its progression. Education, especially self-management plans, are key interventions in COPD. Therapy should be escalated in accordance with the increasing severity of symptoms and disability. Long acting anticholinergics and beta2-agonist inhalers should be prescribed for patients who remain symptomatic despite short-acting bronchodilator therapy. Inhaled steroids should not be used as first line therapy in COPD, but have a role in preventing exacerbations in patients with more advanced disease who suffer recurrent exacerbations. Management strategies consisting of combined modern pharmacotherapy and nonpharmacotherapeutic interventions (eg, pulmonary rehabilitation/exercise training) can effectively improve symptoms, activity levels, and quality of life, even in patients with severe COPD. Acute exacerbations of COPD cause significant morbidity and mortality and should be treated promptly with bronchodilators and a short course of oral steroids; antibiotics should be prescribed for purulent exacerbations. Patients with advanced COPD and respiratory failure require a comprehensive management plan that incorporates structured end-of-life care.http://dx.doi.org/10.1155/2003/567598 |
| spellingShingle | Denis E O’donnell Shawn Aaron Jean Bourbeau Paul Hernandez Darcy D Marciniuk Meyer Balter Gordon Ford Andre Gervais Roger Goldstein Rick Hodder Francois Maltais Jeremy Road Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003 Canadian Respiratory Journal |
| title | Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003 |
| title_full | Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003 |
| title_fullStr | Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003 |
| title_full_unstemmed | Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003 |
| title_short | Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003 |
| title_sort | canadian thoracic society recommendations for management of chronic obstructive pulmonary disease 2003 |
| url | http://dx.doi.org/10.1155/2003/567598 |
| work_keys_str_mv | AT deniseodonnell canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT shawnaaron canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT jeanbourbeau canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT paulhernandez canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT darcydmarciniuk canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT meyerbalter canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT gordonford canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT andregervais canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT rogergoldstein canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT rickhodder canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT francoismaltais canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 AT jeremyroad canadianthoracicsocietyrecommendationsformanagementofchronicobstructivepulmonarydisease2003 |